Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Man Killed in Pedestrian Crash at Highway 41 and Grangeville Boulevard


Victim Hit by Car in Fatal Lemoore Accident

Lemoore, CA (April 1, 2020) – A man was killed in a pedestrian crash in Lemoore. The fatal accident occurred on the morning of April 1 at Highway 41 and Grangeville Boulevard.

A man was hit by a vehicle on northbound Highway 41. Emergency crews found the man lying in the highway. He died at the accident scene. The driver remained at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Lemoore

#93245


March 27, 2020

Man Killed in Crash on Highway 4 at Contra Loma Boulevard

3 Others Injured in Fatal Antioch Accident...


October 23, 2019

3 Killed, 1 Injured in Crash on Highway 88 Near Blue Sky Drive

3 Vehicles Involved in Fatal Ione Accident Ione, CA (October 21, 2019) – Thre...


December 6, 2019

1 Injured in Crash at Watsonville Road and Uvas Road

3 Vehicles Involved in Morgan Hill Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.